Nir Sassi - 09 Oct 2024 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Financial Officer
Signature
/s/ Nir Sassi
Issuer symbol
INDP
Transactions as of
09 Oct 2024
Net transactions value
$0
Form type
4
Filing time
10 Oct 2024, 16:05:13 UTC
Previous filing
23 Jan 2024
Next filing
11 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 09 Oct 2024 Common Stock 75,000 $1.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date.